Female patients are also more likely to take GLP-1 medication, making up approximately 65 percent of all users nationwide
If you notice any of the following, seek emergency medical attention immediately: Swelling of the face, lips, tongue, or throat Trouble swallowing or breathing Severe rash or itching Fainting Very rapid heartbeat Nausea and vomiting The same study found that females were about 4.5 times more likely to experience vomiting when taking GLP-1 drugs
For fiscal years 2019 through 2023, the FDA approved 99% of the approximately 18,000 single-patient expanded access Investigational New Drug requests, according to FDA data
Cieri-Hutcherson NE, Jaenecke A, Bahia A, Lucas D, Oluloro A, Stimmel L, Hutcherson TC
Challenges and perspectives of selenium supplementation in Graves disease and orbitopathy